Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000408097 | SCV000341226 | uncertain significance | not provided | 2018-02-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086033 | SCV000766740 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001086033 | SCV001279639 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Baylor Genetics | RCV001086033 | SCV001524382 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2019-01-03 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000408097 | SCV001785522 | likely benign | not provided | 2021-04-20 | criteria provided, single submitter | clinical testing | Reported previously in an individual undergoing next generation sequencing testing for myopathy, although further information was not provided on this individual (Di Fruscio et al., 2016); This variant is associated with the following publications: (PMID: 25898921) |
Natera, |
RCV001086033 | SCV001456714 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2020-01-07 | no assertion criteria provided | clinical testing |